Evidence map›Paper›PMID 34841466›Full record

ArticleArchives of women's mental health2022

A population-based follow-up study shows high psychosis risk in women with PCOS.

Salla Karjula, Riikka K Arffman, Laure Morin-Papunen, Stephen Franks, Marjo-Riitta Järvelin, Juha S Tapanainen, Jouko Miettunen, Terhi T Piltonen

Open access · hybridAbstract read
In one paragraph

Article in Archives of women's mental health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Gut bacteriome and mood disorders in women with PCOS.Human reproduction (Oxford, England) · 2024
    Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Salla KarjulaDepartment of Obstetrics and Gynecology, University Hospital of Oulu, University of Oulu, Medical Research Centre Oulu and PEDEGO Research Unit, Oulu, Kajaanintie 50, 90014, Oulu, Finland.
Riikka K ArffmanDepartment of Obstetrics and Gynecology, University Hospital of Oulu, University of Oulu, Medical Research Centre Oulu and PEDEGO Research Unit, Oulu, Kajaanintie 50, 90014, Oulu, Finland.
Laure Morin-PapunenDepartment of Obstetrics and Gynecology, University Hospital of Oulu, University of Oulu, Medical Research Centre Oulu and PEDEGO Research Unit, Oulu, Kajaanintie 50, 90014, Oulu, Finland.
Stephen FranksInstitute of Reproductive and Developmental Biology, Imperial College, London, W12 ONN, UK.
Marjo-Riitta JärvelinDepartment of Epidemiology and Biostatistics, Medical Research Council-PHE (Public Health England) Centre for Environment & Health, School of Public Health, Imperial College, London, W2 1PG, UK.
Juha S TapanainenDepartment of Obstetrics and Gynecology, University Hospital of Oulu, University of Oulu, Medical Research Centre Oulu and PEDEGO Research Unit, Oulu, Kajaanintie 50, 90014, Oulu, Finland.
Jouko MiettunenCentre for Life Course Health Research, University of Oulu, Box 5000, FI-90014, Oulu, Finland.
Terhi T PiltonenDepartment of Obstetrics and Gynecology, University Hospital of Oulu, University of Oulu, Medical Research Centre Oulu and PEDEGO Research Unit, Oulu, Kajaanintie 50, 90014, Oulu, Finland. terhi.piltonen@oulu.fi.
Oulu University Hospital · FIImperial College London · GBUniversity of Oulu · FIUniversity of Helsinki · FI

Funding

Department of HealthMedical Research Council G0500539Medical Research Council G0600705Medical Research Council G0802782Medical Research Council G1002319Medical Research Council MC_UU_00011/1Medical Research Council MR/S019669/1
6 · The paper itself

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting up to 18% of women. Besides metabolic and fertility aspects, attention has lately been directed towards the detrimental effect of PCOS on psychological health. The objective of the study was to investigate whether women with PCOS are at higher risk for psychotic disorders. The study population derives from the Northern Finland Birth Cohort 1966 (N = 5889 women). The women with PCOS were identified by two simple questions on oligo-amenorrhea and hirsutism at age 31. Women reporting both symptoms were considered PCOS (N = 124) and asymptomatic women as controls (N = 2145). The diagnosis of psychosis was traced using multiple national registers up to the year 2016. Symptoms of psychopathology were identified using validated questionnaires at age 31. Women with PCOS showed an increased risk for any psychosis by age 50 (HR [95% CI] 2.99, [1.52-5.82]). Also, the risk for psychosis after age 31 was increased (HR 2.68 [1.21-5.92]). The results did not change after adjusting for parental history of psychosis, nor were they explained by body mass index or hyperandrogenism at adulthood. The scales of psychopathology differed between women with PCOS and non-PCOS controls showing more psychopathologies among the affected women. PCOS cases were found to be at a three-fold risk for psychosis, and they had increased psychopathological symptoms. PCOS should be taken into consideration when treating women in psychiatric care. More studies are required to further assess the relationship between PCOS and psychotic diseases.

Indexed as

HyperandrogenismPolycystic Ovary SyndromePsychotic DisordersAdultFemaleFollow-Up StudiesHirsutismHumansMiddle AgedHirsutismPCOSPolycystic ovary syndromePsychosisTestosterone

Identifiers

PMID34841466
PMCPMC8921102
OpenAlexW3215827647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.